Stryker announces board changes following Annual Meeting of Shareholders
May 05 2022 - 8:00AM
Stryker (NYSE: SYK) announced that on May 4, 2022, the company’s
board of directors approved board leadership and committee
assignment changes, naming Sherilyn S. McCoy to replace Allan C.
Golston as Lead Independent Director, and Mary K. Brainerd to
replace Ms. McCoy as Chair of the Governance and Nominating
Committee.
Mr. Golston has been a member of Stryker’s Board of Directors
since 2011 and has served as Lead Independent Director since 2016
and Chair of the Compensation Committee since 2021.
“Allan has provided strong leadership for our independent
directors and has helped us build a highly effective and diverse
board,” said Kevin A. Lobo, Chair & Chief Executive
Officer.
Ms. McCoy has been a member of Stryker’s Board of Directors
since 2018 and has served as Chair of the Governance and Nominating
Committee since 2019. Ms. Brainerd has been a member of Stryker’s
Board of Directors since 2017 and has served on each of the board
committees during her tenure.
“We are proud to have independent directors with varied
experiences, perspectives and talents serving on our board,” said
Mr. Lobo. “Stryker is committed to diversity and board refreshment,
including rotation of committee chair assignments, which enhances
our ability to support our customers to make healthcare
better.”
The board leadership and committee assignments are now as
follows below:
- Chair of the Board – Kevin A. Lobo
- Lead Independent Director – Sherilyn S. McCoy
- Audit Committee – Andrew K. Silvernail (Chair), Srikant M.
Datar, Lisa M. Skeete Tatum and Rajeev Suri
- Compensation Committee – Allan C. Golston (Chair), Mary K.
Brainerd, Giovanni Caforio and Sherilyn S. McCoy
- Governance and Nominating Committee – Mary K. Brainerd (Chair),
Giovanni Caforio, Allan C. Golston, Sherilyn S. McCoy and Ronda E.
Stryker
About StrykerStryker is one of
the world’s leading medical technology companies and, together with
its customers, is driven to make healthcare better. The company
offers innovative products and services in Medical and Surgical,
Neurotechnology, Orthopaedics and Spine that help improve patient
and healthcare outcomes. Alongside its customers around the world,
Stryker impacts more than 100 million patients annually. More
information is available at www.stryker.com.
Contacts
For investor inquiries please contact:Preston
Wells, Vice President, Investor Relations at 269-385-2600 or
preston.wells@stryker.com
For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at
269-385-2600 or yin.becker@stryker.com
Stryker (NYSE:SYK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Apr 2023 to Apr 2024